1st Total Artificial Heart Patient Discharged from Ege University in Turkey

Former Professional Soccer Player Waits for Donor Heart at   Home Using the Freedom® Portable Driver to Power His Total Artificial Heart

SynCardia Systems, Inc.,   manufacturer of the world’s first and only FDA, Health Canada and CE (Europe)   approved Total Artificial Heart, announced today that for the first time in   Izmir, Turkey, a patient implanted with the SynCardia temporary Total Artificial   Heart has been discharged from the hospital. On Sept. 26, 57-year-old   Nurullah Balik was discharged from Ege University Hospital to wait for a   matching donor heart at home using the Freedom® portable driver to power his   Total Artificial Heart.

“I am very happy to return home,”   said Mr. Balik, a former professional soccer player. “Thanks to the Freedom   portable driver, now I can enjoy my daily routine in the town where I live   instead of in the hospital.”

In 2002, Mr. Balik suffered a heart attack and received   several stents. Five years later, he was diagnosed with congestive heart   failure. Over time, his condition continued to deteriorate and in May 2012,   he was diagnosed with heart failure affecting both sides of his heart   (biventricular failure). In addition, three of his four heart valves were   leaking. He was admitted to the hospital on July 17.

“This patient was in severe biventricular failure with   valvular insufficiency,” said Prof. Dr. Mustafa Ozbaran, head of the   Transplant and Assist Device Program. “The best option for our patient was   the SynCardia Total Artificial Heart”… read more at SynCardia.com

Posted in AZBio News, Members.